H. Matsuo et al., THE COMPLEMENT-MEDIATED BUT NOT MANNOSE RECEPTOR-MEDIATED PHAGOCYTOSIS IS INVOLVED IN THE HEPATIC-UPTAKE OF CETYLMANNOSIDE-MODIFIED LIPOSOMES IN-SITU, Journal of drug targeting., 2(2), 1994, pp. 141-146
In the elimination of injected liposomes in vivo, it is considered tha
t several serum components play an important role on hepatic uptake of
them. This study was conducted to clarify the hepatic uptake mechanis
m of cetylmannoside (Man)-modified multilamellar vesicles (Man-MLV) us
ing perfused rat liver. In the presence of serum, Man-MLV was taken up
by the liver depending on the serum concentration, and it showed an a
pproximately two-fold higher accumulation than MLV without any surface
modifications (PC-MLV). These heptic uptakes of liposomes were obviou
sly inhibited by preheating the serum at 56-degrees-C for thirty minut
es or by the treatment with anti-rat C3 antiserum. Further, SDS-PAGE f
ollowed by immunoblot analysis showed the deposition of iC3b on the op
sonized Man-MLV. These results obtained in the present study suggested
that hepatic uptake of Man-MLV was mainly mediated by complement rece
ptor rather than mannose receptor on Kupffer cells in vivo.